Kennedy Capital Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.46M | Sell |
134,890
-2,614
| -2% | -$144K | 0.18% | 209 |
|
|
2025
Q1 | $6.65M | Sell |
137,504
-184,022
| -57% | -$8.9M | 0.16% | 219 |
|
|
2024
Q4 | $12.4M | Buy |
321,526
+54,493
| +20% | +$2.1M | 0.28% | 99 |
|
|
2024
Q3 | $12M | Sell |
267,033
-23,049
| -8% | -$1.04M | 0.27% | 100 |
|
|
2024
Q2 | $10.1M | Sell |
290,082
-7,986
| -3% | -$277K | 0.21% | 152 |
|
|
2024
Q1 | $8.62M | Sell |
298,068
-6,722
| -2% | -$194K | 0.18% | 205 |
|
|
2023
Q4 | $6.99M | Sell |
304,790
-14,744
| -5% | -$338K | 0.15% | 241 |
|
|
2023
Q3 | $5.33M | Sell |
319,534
-84,114
| -21% | -$1.4M | 0.13% | 274 |
|
|
2023
Q2 | $11.1M | Buy |
403,648
+72,366
| +22% | +$2M | 0.26% | 120 |
|
|
2023
Q1 | $7.62M | Sell |
331,282
-18,851
| -5% | -$434K | 0.22% | 156 |
|
|
2022
Q4 | $3.82M | Buy |
350,133
+251,046
| +253% | +$2.74M | 0.11% | 319 |
|
|
2022
Q3 | $835K | Sell |
99,087
-89
| -0.1% | -$750 | 0.02% | 505 |
|
|
2022
Q2 | $784K | Buy |
99,176
+1,911
| +2% | +$15.1K | 0.02% | 503 |
|
|
2022
Q1 | $2.3M | Sell |
97,265
-8,129
| -8% | -$192K | 0.05% | 425 |
|
|
2021
Q4 | $3.6M | Sell |
105,394
-6,871
| -6% | -$235K | 0.08% | 392 |
|
|
2021
Q3 | $1.99M | Buy |
112,265
+40,318
| +56% | +$714K | 0.04% | 477 |
|
|
2021
Q2 | $3.23M | Sell |
71,947
-3,571
| -5% | -$160K | 0.07% | 433 |
|
|
2021
Q1 | $1.96M | Buy |
+75,518
| New | +$1.96M | 0.04% | 517 |
|